Eric Nolen-Doerr MD

Published on 1/13/2022

Angelidi AM, Papadaki A, Nolen-Doerr E, Boutari C, Mantzoros CS. The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials. Metabolism. 2022 04; 129:155136. PMID: 35032545.

Published on 10/30/2020

Papadaki A, Nolen-Doerr E, Mantzoros CS. The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults. Nutrients. 2020 Oct 30; 12(11). PMID: 33143083.

Published on 9/1/2019

Nolen-Doerr E, Stockman MC, Rizo I. Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity. Curr Obes Rep. 2019 Sep; 8(3):284-291. PMID: 31124035.

Published on 8/8/2019

Farr OM, Upadhyay J, Rutagengwa C, DiPrisco B, Ranta Z, Adra A, Bapatla N, Douglas VP, Douglas KAA, Nolen-Doerr E, Mathew H, Mantzoros CS. Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti-obesity therapies. Diabetes Obes Metab. 2019 11; 21(11):2459-2464. PMID: 31282006.

Published on 2/1/2019

Papathanasiou AE, Nolen-Doerr E, Farr OM, Mantzoros CS. GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans. Eur J Endocrinol. 2019 Feb 01; 180(2):R59-R71. PMID: 30475221.

Published on 11/1/2018

Pilitsi E, Farr OM, Polyzos SA, Perakakis N, Nolen-Doerr E, Papathanasiou AE, Mantzoros CS. Pharmacotherapy of obesity: Available medications and drugs under investigation. Metabolism. 2019 03; 92:170-192. PMID: 30391259.

Published on 7/1/2018

Nolen-Doerr E, Crick K, Saha C, de Groot M, Pillay Y, Shubrook JH, Donley D, Hornsby WG. Six-Minute Walk Test as a Predictive Measure of Exercise Capacity in Adults with Type 2 Diabetes. Cardiopulm Phys Ther J. 2018 Jul; 29(3):124-129. PMID: 31379471.